Cushing's disease (CD) is due to an adrenocorticotrophin (ACTH)-secreting pituitary tumour leading to excess cortisol production. Transphenoidal surgery (TSS) remains the mainstay of treatment, effective in 80% of cases. This study investigated the desmopressin (DDAVP) and corticotrophin-releasing hormone (CRH) stimulation tests as predictors of long-term outcome after TSS.
the DDAVP stimulation test. A positive response to both tests revealed a positive predictive value of 100%, and a negative response to both tests had a negative predictive value of 100%.
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Distinct injury markers for the early detection and prognosis of incident acute kidney injury in critically ill adults with preserved kidney function Acute kidney injury (AKI) is common in the critically ill and is associated with a high hospital mortality rate. In this patient group, the use of biomarkers to detect AKI is hindered by the heterogeneity of injury and the effects of prevalent AKI. A single biomarker is unlikely to reflect the multiple pathways involved.
This study attempted to improve diagnostic performance by using three distinct urine markers: neutrophil gelatinase-associated lipocalin (NGAL), L-type fatty acid-binding protein (L-FABP) and cystatin C. The authors measured these markers in a large nested case-control study of critically ill patients to assess whether they improved prediction of the development of incident AKI, and subsequent dialysis and death, compared with a single marker alone.
Urine NGAL, L-FABP and cystatin C and serum creatinine were measured at study enrolment and after 48 h. AKI cases were identified (n ¼ 130), and compared to controls (n ¼ 250) without AKI, by measurement of serum creatinine on patients admitted to one of four intensive care units. Patients were followed up prospectively until hospital discharge.
Urine cystatin C did not show any difference between those with and without AKI and was not included in subsequent analysis. NGAL and L-FABP
